NewAmsterdam Pharma Company N.V. Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay
NewAmsterdam Pharma Company N.V. (NAMS) reported Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay of 3.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-18.
Financial Statements › Notes › Compensation Related Costs › Defined Contribution Plan
us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent · last filed 2026-02-18
- NewAmsterdam Pharma Company N.V. defined contribution plan, employer matching contribution, percent of employees' gross pay for fiscal 2025 was 3.00%, a 0.00% change from fiscal 2024.
- NewAmsterdam Pharma Company N.V. defined contribution plan, employer matching contribution, percent of employees' gross pay for fiscal 2024 was 3.00%, a 0.00% change from fiscal 2023.
- NewAmsterdam Pharma Company N.V. defined contribution plan, employer matching contribution, percent of employees' gross pay for fiscal 2023 was 3.00%.
| Period end | Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay 12 month |
|---|---|
| 2025-12-31 | 3.00% 10-K · filed 2026-02-18 |
| 2024-12-31 | 3.00% 10-K · filed 2025-02-26 |
| 2023-12-31 | 3.00% 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |